The Impact of Diabetes Counseling and Education Clinical and Cost Outcomes From a Large Population of US Managed Care Patients With Type 2 Diabetes

被引:6
|
作者
Sullivan, Sean D. [1 ]
Dalal, Mehul R. [2 ]
Burke, James P. [3 ]
机构
[1] Univ Washington, Seattle, WA 98195 USA
[2] Sanofi US Inc, Bridgewater, NJ USA
[3] OPTUM Insight, Eden Prairie, MN USA
来源
DIABETES EDUCATOR | 2013年 / 39卷 / 04期
关键词
IMPROVED GLYCEMIC CONTROL; SELF-MANAGEMENT; GLUCOSE CONTROL; MELLITUS; ADULTS; METAANALYSIS; HEMOGLOBIN; BENEFITS;
D O I
10.1177/0145721713486525
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose The purpose of this study is to examine outcomes in adult patients with type 2 diabetes mellitus who received diabetes counseling and education (C/E) services compared with those who did not. Methods A matched, retrospective cohort study of 17 483 C/E recipients and 17 470 non-C/E controls was followed for up to 12 months. Outcomes included glycemic control (glycosylated hemoglobin A1C levels <7.0%), hypoglycemic events, and health care utilization and costs. Results Compared with the non-C/E group, patients in the C/E group had significantly lower A1C (7.7% vs 7.2%) and were more likely to achieve glycemic control at 6 months' follow-up; they were also more likely to have a hypoglycemic event. During the 1-year period following the index date, C/E recipients had more inpatient visits (0.21 vs 0.20 visits per patient) and ambulatory visits (21.5 vs 18.6 visits per patient) compared with non-C/E controls. The increased use of health care services in the C/E groups was associated with $2388 higher annual overall costs and $827 higher diabetes-related costs. Conclusions Diabetes C/E is associated with improved glycemic control, albeit with a slight increase in the risk of hypoglycemia. C/E was associated with higher health care costs across 12 months. Further analyses are needed to evaluate long-term cost-effectiveness of diabetes counseling and education.
引用
收藏
页码:523 / 531
页数:9
相关论文
共 50 条
  • [31] The Impact of Type 2 Diabetes on the Outcomes of Solid Organ Transplants in the US
    Stepanova, Maria
    Kumar, Ameeta
    Brandt, Pamela
    Gundurao, Nagashree
    Cusi, Kenneth
    Younossi, Zobair
    DIABETES, 2023, 72
  • [32] The Effects of a Diabetes Education Program on Clinical Outcomes in Patients with Diabetes
    Cadag, Stefan
    Krymskaya, Marina
    DeJesus, Jenny
    Srivastava, Artee
    Craig, William
    Regester, Jennifer
    Levine, Randi
    Morrow, Nalaie
    Poretsky, Leonid
    DIABETES, 2009, 58 : A241 - A241
  • [33] Treatment patterns and persistence among elderly patients with type 2 diabetes: data from a US managed care claims database
    Gravenstein, S.
    Thompson, S. F.
    Stefanacci, R. G.
    DIABETOLOGIA, 2009, 52 : S352 - S352
  • [34] Impact of population management with direct physician feedback on care of patients with type 2 diabetes
    Grant, RW
    Hamrick, HE
    Sullivan, CM
    Dubey, AK
    Chueh, HC
    Cagliero, E
    Meigs, JB
    DIABETES CARE, 2003, 26 (08) : 2275 - 2280
  • [35] Impact of population management with direct physician feedback on care of patients with type 2 diabetes
    Grant, R
    Hamrick, H
    Sullivan, C
    Cagliero, E
    Meigs, J
    DIABETES, 2003, 52 : A262 - A262
  • [36] Impact of a Comprehensive Clinical and Education Program on Clinical Parameters in Latino Patients with Type 2 Diabetes
    Caballero, A. Enrique
    Millan-Ferro, Andreina
    Garcia-Dol-Agaray, Gabriela
    Romero-Ibarguengoitia, Maria Elena
    Gautam, Shiva
    DIABETES, 2016, 65 : A59 - A59
  • [37] Clinical Characteristics and Outcomes in Patients with Type 2 Diabetes (T2D) Adding Insulin Glargine to Exenatide or Exenatide to Insulin Glargine in a US Managed Care Setting
    Levin, Philip
    Wei, Wenhui
    Wang, Li
    Damon, Douglas
    Baser, Onur
    DIABETES, 2011, 60 : A266 - A266
  • [38] Diabetes managed care and clinical outcomes: The Harbor City, California Kaiser permanente Diabetes Care System
    Domurat, ES
    AMERICAN JOURNAL OF MANAGED CARE, 1999, 5 (10): : 1299 - 1307
  • [39] Excess costs of medical care for patients with diabetes in a managed care population
    Selby, JV
    Ray, GT
    Zhang, DY
    Colby, CJ
    DIABETES CARE, 1997, 20 (09) : 1396 - 1402
  • [40] Canagliflozin treatment of Hispanic and non-Hispanic patients with type 2 diabetes in a US managed care setting
    Chow, Wing
    Buysman, Erin
    Rupnow, Marcia F. T.
    Aguilar, Richard
    Henk, Henry J.
    CURRENT MEDICAL RESEARCH AND OPINION, 2016, 32 (01) : 13 - 22